Nanomedicine News

RSS

Researchers Fabricate Flexible Sensor Using Gold Nanoparticles for e-Skin Applications

Using tiny gold particles and a kind of resin, a team of scientists at the Technion-Israel Institute of Technology has discovered how to make a new kind of flexible sensor that one day could be integrated into electronic skin, or e-skin.

9 Jul 2013

bpifrance Grants Nanobiotix €9 Million to Advance NBTXR3 for Liver Cancer

NANOBIOTIX, a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today it has secured c.€9 million in funding from bpifrance (formerly OSEO) of which €2.8 million is directly attributable to the Company.

5 Jul 2013

BioAlliance Pharma Announces Funding from bpifrance for Launch of Nano Innovation for Cancer(NICE) Consortium

BioAlliance Pharma SA (Euronext Paris - BIO), a Company dedicated to the development of orphan oncology products and supportive care products, today announced funding of almost €9 million from bpifrance through a Strategic Industrial Innovation (ISI) program.

4 Jul 2013

CEA-Leti Announces Funding from bpifrance to Accelerate Preclinical Development of Cancer Detecting Nanoparticles

CEA-Leti announced today €1 million in funding from bpifrance to accelerate preclinical development of a liver-cancer detection system called LipImage 815™.

4 Jul 2013

Laser and Nanotechnology Packed Device Reads Bacteria’s Metabolic Activity

Nano and laser technology packed into small device tests antibiotic treatment in minutes

3 Jul 2013

Positive Results from Novavax Phase 1 Trial of Nanoparticle RSV Vaccine

Novavax, Inc. today announced positive top-line safety and immunogenicity data for its respiratory syncytial virus (RSV) vaccine candidate from a dose-ranging Phase 1 study in elderly adults. All subject groups receiving the recombinant fusion (F) protein nanoparticle vaccine candidate exhibited antibody responses against RSV at 28 and 56 days post-immunization, with rises in serum anti-F immunoglobulin G (IgG) antibody levels.

From Novavax Inc. 3 Jul 2013

Novel Nanofiber Mesh Simultaneously Realizes Thermotherapy and Chemotherapy of Tumors

A research team headed by Dr. Mitsuhiro Ebara, a MANA Scientist of the Biomaterials Unit of the International Center for Materials Nanoarchitectonics (WPI-MANA, NIMS) developed a new nanofiber mesh which is capable of simultaneously realizing thermotherapy (hyperthermia) and chemotherapy (treatment with anticancer drugs) of tumors. Using this nanofiber mesh, the team succeeded in efficiently inducing natural death (apoptosis) of epithelial cancer cells.

From National Institute for Materials Science 3 Jul 2013

NanoViricides Submits Letter of Intent to File DengueCide Orphan Drug Application with the EMA

NanoViricides, Inc. (the "Company") announced today that it has submitted its letter of intent to file an Orphan Drug Application with the European Medicines Agency (EMA) for DengueCide™, its drug candidate for the treatment of dengue and dengue hemorrhagic fever.

From NanoViricides, Inc 2 Jul 2013

DNA Nanostructure-Based Vaccine May Help Address Nicotine Dependence

A chemical component present in the nightshade family of plants is one of the world’s most tenaciously addictive substances. It is the nicotine contained in tobacco and found in high concentrations in cigarettes. Smoking remains a global scourge; in the U.S. it is the leading source of preventable death.

From Arizona State University 2 Jul 2013

Gold Nanodot Obstacle Arrays Used in Study of Malignant Activity of Cancer Cells

Evidence is mounting that the development and spread of cancer, long attributed to gene expression and chemical signaling gone awry, involves a biomechanical component as well. Researchers at Lawrence Berkeley National Laboratory (Berkeley Lab) have added to this body of evidence by demonstrating that the malignant activity of a critical cellular protein system can arise from what essentially are protein traffic jams.

From Lawrence Berkeley National Laboratory 2 Jul 2013

Nanomedicine News

Researchers Fabricate Flexible Sensor Using Gold Nanoparticles for e-Skin Applications

bpifrance Grants Nanobiotix €9 Million to Advance NBTXR3 for Liver Cancer

BioAlliance Pharma Announces Funding from bpifrance for Launch of Nano Innovation for Cancer(NICE) Consortium

CEA-Leti Announces Funding from bpifrance to Accelerate Preclinical Development of Cancer Detecting Nanoparticles

Laser and Nanotechnology Packed Device Reads Bacteria’s Metabolic Activity

Positive Results from Novavax Phase 1 Trial of Nanoparticle RSV Vaccine

Novel Nanofiber Mesh Simultaneously Realizes Thermotherapy and Chemotherapy of Tumors

NanoViricides Submits Letter of Intent to File DengueCide Orphan Drug Application with the EMA

DNA Nanostructure-Based Vaccine May Help Address Nicotine Dependence

Gold Nanodot Obstacle Arrays Used in Study of Malignant Activity of Cancer Cells

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Sustainable Future for Carbon Nanotubes

Sustainable ZnO Nanoparticles for Methylene Blue Cleanup

Enhancing Material Properties through Nanotube Encapsulation

Modeling the Growth of Hexagonal Boron Nitride for Next-Generation Applications

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials